Rallybio

+$0.69 (+3.87%) Today
$0.00 (0.00%) As of 8:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Rallybio and other ETFs, options, and stocks.

About RLYB

Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focuses in the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease.

CEO
Martin W. MacKay, PhD
Employees
—
Headquarters
New Haven, Connecticut
Founded
2018

RLYB Key Statistics

Market Cap
492.07M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
61.38K
High Today
$18.98
Low Today
$16.81
Open Price
$17.67
Volume
108.20K
52 Week High
$25.78
52 Week Low
$10.05

RLYB Earnings

-$2.80
-$1.87
-$0.93
$0.00
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 15, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure